US Patent Issued to CSPC MEGALITH BIOPHARMACEUTICAL on Nov. 4 for "Anti-trophoblast cell surface antigen 2 (TROP2) antibodies and antibody drug conjugates comprising same" (California Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,818, issued on Nov. 4, was assigned to CSPC MEGALITH BIOPHARMACEUTICAL Co. LTD. (Hebei, China).

"Anti-trophoblast cell surface antigen 2 (TROP2) antibodies and antibody drug conjugates comprising same" was invented by Yuxi Shan (Sacramento, Calif.), Lixin Feng (Sacramento, Calif.), Ryan Joseph Browde (Sacramento, Calif.), Lisha Allen (Sacramento, Calif.) and Ru Bin Yang (Sacramento, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are anti-Trophoblast cell surface antigen 2 (TROP2) antibodies and fragments thereof. Also provided are isolated nucleic acid molecules that encode anti-TROP2 antibodies, vectors comprising such nucleic acids,...